SELLAS Life Sciences Group, Inc. (SLS) stock
SLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$17.95−1.20 (-6.27%)
Close on Nov 18, 2026Market cap $3.62BP/E –Yield –
SELLAS Life Sciences market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
SELLAS Life Sciences's market cap was $1.70B on Nov 11, 2026, against $202.63M a year earlier. Over the last 5 years it ranged from $18.17M to $2.69B, with a median of $74.50M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.70B | +260.5% |
| 2025 | Dec 31, 2025 | $471.55M | +604.2% |
| 2024 | Dec 31, 2024 | $66.96M | +122.5% |
| 2023 | Dec 29, 2023 | $30.10M | -38.1% |
| 2022 | Dec 30, 2022 | $48.59M | -44.7% |
| 2021 | Dec 31, 2021 | $87.78M | +59.7% |
| 2020 | Dec 31, 2020 | $54.97M | +181.0% |
| 2019 | Dec 31, 2019 | $19.56M | -22.4% |
| 2018 | Dec 31, 2018 | $25.22M | -92.3% |
| 2017 | Dec 29, 2017 | $328.71M | -47.3% |
| 2016 | Dec 30, 2016 | $624.26M | -91.3% |
| 2015 | Dec 31, 2015 | $7.17B | +30.3% |
| 2014 | Dec 31, 2014 | $5.50B | -64.8% |
| 2013 | Dec 31, 2013 | $15.61B | +403.1% |
| 2012 | Dec 31, 2012 | $3.10B | +412.0% |
| 2011 | Dec 30, 2011 | $606.09M | – |
See a number that looks wrong?